B
ITCI
Bailard’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,480
| Closed | -$1.07M | – | 829 |
|
|
2024
Q1 | $1.07M | Sell |
15,480
-1,600
| -9% | -$111K | 0.03% | 295 |
|
|
2023
Q4 | $1.22M | Buy |
17,080
+200
| +1% | +$14.3K | 0.04% | 264 |
|
|
2023
Q3 | $879K | Hold |
16,880
| – | – | 0.03% | 288 |
|
|
2023
Q2 | $1.07M | Buy |
16,880
+1,400
| +9% | +$88.6K | 0.04% | 264 |
|
|
2023
Q1 | $838K | Sell |
15,480
-14,600
| -49% | -$791K | 0.03% | 294 |
|
|
2022
Q4 | $1.59M | Sell |
30,080
-2,100
| -7% | -$111K | 0.06% | 212 |
|
|
2022
Q3 | $1.5M | Hold |
32,180
| – | – | 0.06% | 211 |
|
|
2022
Q2 | $1.84M | Hold |
32,180
| – | – | 0.07% | 192 |
|
|
2022
Q1 | $1.97M | Hold |
32,180
| – | – | 0.07% | 209 |
|
|
2021
Q4 | $1.68M | Sell |
32,180
-126,000
| -80% | -$6.59M | 0.05% | 214 |
|
|
2021
Q3 | $5.9M | Sell |
158,180
-13,520
| -8% | -$504K | 0.2% | 108 |
|
|
2021
Q2 | $7.01M | Hold |
171,700
| – | – | 0.24% | 97 |
|
|
2021
Q1 | $5.83M | Buy |
171,700
+400
| +0.2% | +$13.6K | 0.22% | 99 |
|
|
2020
Q4 | $5.45M | Buy |
171,300
+39,300
| +30% | +$1.25M | 0.25% | 85 |
|
|
2020
Q3 | $3.39M | Sell |
132,000
-9,000
| -6% | -$231K | 0.18% | 109 |
|
|
2020
Q2 | $3.62M | Buy |
+141,000
| New | +$3.62M | 0.2% | 95 |
|